Icon

VAZCULEP (nda204300)- (10MG/ML (10MG/ML),50MG/5ML (10MG/ML),100MG/10ML (10MG/ML))

PHENYLEPHRINE HYDROCHLORIDE EXELA PHARMA
10MG/ML (10MG/ML),50MG/5ML (10MG/ML),100MG/10ML (10MG/ML)
No Yes
Expired Expired
None None
None No
VAZCULEP (phenylephrine hydrochloride) Injection is an alpha-1 adrenergic receptor agonist indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.
15 0 14
Total Other Developers 13
Drugs with Suitability No
10MG/ML (10MG/ML) ** ** - - -
50MG/5ML (10MG/ML) ** ** - - -
100MG/10ML (10MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 11
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ******** ************ ****** ***. *********** *** *** *****-***** ******, ************, ** *** ***, ****** (***) ***
****** ****** ****** *************** ******* ******* *********** ****** **. ***/*/*, *****, ******, *********, ******* ******, ***** (***) ***
****** ***** ****** *** ***** ****** ******* *********** **** **: **-**, **, **, **-**, **. **. ***, ***, *** & ***, ***** ***, *****, ************ *******, ********** ******, ********** ********, *********, ********* ******, ***** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. ***/***-****** / **** **.***/****-*********** , *******-***** ******* , ****** -******, ******, *********, ******* ******, ***** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. * ** **, *******, **** ******* ******, *******-***** *******, **. *-*, ****** ******, *********, ******* ******, ***** (***) ***
****** ****** ****** ******** ******* *********** ****** **.*** & ***. ******************, **************** (****), *********** (********), *************, ***** **** ******, ***** (***) ***
****** ******* ****** ******* ****** ******* *********** ****-***, ******* *****, ****** **** ****, ***. ****** *******, ****** *****, *******, ******** ******* ******, ***** (***) ***
****** ****** **** ****** **** *****. **., ***. *********** ********** ******** *********** ****, ****** ********, ******, ****** ******, ***** (***) ***
****** ****** ****** ****** ******* *********** ****** **. ***, ******* ****, ***** ***
****** ******** ******* ****-****** *********** ************** **.,***. (*** ****) *********** **, ** ***** ****, ******* **** *** *** ********** *********** **** ******* ******, *******, ******* ******, ***** (***) ***
****** ********* **** *** ********* **** ***, *** *********** **** *. **** ****** **** ***** ********* ******, ******* ****, ******** (**) *****, ****** ****** (***) ***
****** ********* **** *** ********* **** ***, *** *********** **** *. ******* ****** **** ***** ********* ******, ******* ****, ******** (**) *****, ****** ****** (***) ***
****** ***** ****** ***** ****** ************ ******* *********** ****-***, **** **: *, ** ** **, ***, ** ** **, ****, *****, ***, ************ *******, ********** ******, **********, ********* ******, ***** (***) ***
****** ****** ****** *************** ******* ******* *********** **** ** ** & **, ******* ******* ******** **** *******-***** *.*. **. **, ***.: ******, ***.: ******, *********, ** ******, ***** (***) ***
****** ****** ****** *************** ******* ******* *********** **** **. **, ******* ******* ******** **** *******-***** *.*. **. **, ***.: ******, ***. ******, *********, ** ******, ***** (***) ***
****** ****** ****** *************** ******* ******* *********** ****** **. ***/*/*, *****, ******, *********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.